2011
DOI: 10.1136/thx.2010.142646
|View full text |Cite
|
Sign up to set email alerts
|

Neural respiratory drive, pulmonary mechanics and breathlessness in patients with cystic fibrosis

Abstract: Background Neural respiratory drive (NRD) measured from the diaphragm electromyogram (EMGdi) reflects the load/capacity balance of the respiratory muscle pump and is a marker of lung disease severity. EMGdi measurement is invasive, but recording the EMG from the parasternal intercostal muscles using surface electrodes (sEMGpara) could provide a non-invasive method of assessing NRD and disease severity. Objectives To test the hypothesis that NRD measured by sEMGpara correlates with EMGdi, to provide an index of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
146
2
5

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 112 publications
(164 citation statements)
references
References 31 publications
(29 reference statements)
11
146
2
5
Order By: Relevance
“…The potential utility of parasternal intercostal muscle EMG (EMGpara) measurements as a marker of NRD has been established in both clinical and laboratory settings, in health and disease. Relationships between EMGpara and disease severity in obstructive lung diseases have been demonstrated (Maarsingh et al, 2002;Reilly et al, 2011;Steier et al, 2011;Reilly et al, 2012), along with increases in EMGpara in response to externally-imposed respiratory load in healthy subjects (Reilly et al, 2013). Differences between healthy individuals and those with lung disease have also been demonstrated Murphy et al, 2011;Reilly et al, 2011;Steier et al, 2011), via comparison to small groups of matched individuals.…”
Section: Introductionmentioning
confidence: 89%
See 4 more Smart Citations
“…The potential utility of parasternal intercostal muscle EMG (EMGpara) measurements as a marker of NRD has been established in both clinical and laboratory settings, in health and disease. Relationships between EMGpara and disease severity in obstructive lung diseases have been demonstrated (Maarsingh et al, 2002;Reilly et al, 2011;Steier et al, 2011;Reilly et al, 2012), along with increases in EMGpara in response to externally-imposed respiratory load in healthy subjects (Reilly et al, 2013). Differences between healthy individuals and those with lung disease have also been demonstrated Murphy et al, 2011;Reilly et al, 2011;Steier et al, 2011), via comparison to small groups of matched individuals.…”
Section: Introductionmentioning
confidence: 89%
“…Previous studies (Murphy et al, 2011;Reilly et al, 2011;Steier et al, 2011) including measurements of EMGpara in healthy individuals have recruited relatively small numbers of subjects from staff and students of respiratory physiology departments.…”
Section: Critique Of the Methodsmentioning
confidence: 99%
See 3 more Smart Citations